Trial Profile
A Multinational, Multi-center, Randomized, Double-blind, Active Comparator, Phase III Clinical Trial to Evaluate the Efficacy and Safety of Donepezil Transdermal Patch in Patients With Alzheimer's Disease
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 18 Apr 2022
Price :
$35
*
At a glance
- Drugs Donepezil (Primary) ; Donepezil (Primary)
- Indications Alzheimer's disease
- Focus Therapeutic Use
- Acronyms IPI-003
- Sponsors ICURE
- 16 Nov 2021 According to an ICURE media release, data presented at the Conference on Clinical Trials of Alzheimers Disease (CTAD) 2021.
- 10 Feb 2021 Status changed from recruiting to completed.
- 18 Feb 2019 Planned End Date changed from 31 Jul 2019 to 30 Nov 2019.